Long-term effects of pergolide in the treatment of restless legs syndrome

被引：78
|
作者：
Stiasny, K
Wetter, TC
Winkelmann, J
Brandenburg, U
Penzel, T
Rubin, M
Hundemer, HP
Oertel, WH
Trenkwalder, C
机构：
[1] Univ Marburg, Dept Neurol, Ctr Nervous Dis, D-35033 Marburg, Germany
[2] Univ Marburg, Dept Internal Med, Marburg, Germany
[3] Lilly Deutschland GMBH, Bad Homburg, Germany
来源：
NEUROLOGY | 2001年 / 56卷 / 10期
关键词：
D O I：
10.1212/WNL.56.10.1399
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
An open follow-up of a controlled study in patients with restless legs syndrome (RLS) shows that the beneficial effect of pergolide on RLS symptoms persists throughout at least 1 year. Twenty-two patients of 28 (78.6%) continued to take pergolide. Polysomnographic measurements showed a persistent improvement of PLM index, PLMS arousal index, total sleep time, and sleep efficiency (p = 0.0001). Side effects, in particular nausea, were common but were well controlled by domperidone in most patients.
引用
收藏
页码：1399 / 1402
页数：4
相关论文
共 50 条
  • [21] Augmentation and tolerance with long-term pramipexole treatment of restless legs syndrome (RLS)
    Winkelman, JW
    Johnston, L
    SLEEP MEDICINE, 2004, 5 (01) : 9 - 14
  • [22] Long-term use of pramipexole in the management of restless legs syndrome
    Lipford, Melissa C.
    Silber, Michael H.
    SLEEP MEDICINE, 2012, 13 (10) : 1280 - 1285
  • [23] LONG-TERM USE OF PRAMIPEXOLE IN THE MANAGEMENT OF RESTLESS LEGS SYNDROME
    Lipford, M. C.
    Silber, M. H.
    SLEEP, 2011, 34 : A202 - A202
  • [24] LONG-TERM TREATMENT OF A PATIENT WITH SEVERE RESTLESS LEGS SYNDROME USING INTRATHECAL MORPHINE
    Hornyak, Magdolna
    Kaube, Holger
    NEUROLOGY, 2012, 79 (24) : 2361 - 2362
  • [25] Pergolide in the management of restless legs syndrome: An extended study
    Silber, MH
    Shepard, JW
    Wisbey, JA
    SLEEP, 1997, 20 (10) : 878 - 882
  • [26] Pergolide: treatment of choice in Restless Legs Syndrome (RLS) and Nocturnal Myoclonus Syndrome (NMS). Longterm follow up on pergolide
    J. Staedt
    H. Hünerjäger
    E. Rüther
    G. Stoppe
    Journal of Neural Transmission, 1998, 105 : 265 - 268
  • [27] Reduced response to gabapentin enacarbil in restless legs syndrome following long-term dopaminergic treatment
    Garcia-Borreguero, Diego
    Cano-Pumarega, Irene
    Garcia Malo, Celia
    Cruz Velarde, Jose Antonio
    Jose Granizo, Juan
    Wanner, Vivian
    SLEEP MEDICINE, 2019, 55 : 74 - 80
  • [28] Long-term Maintenance Treatment of Restless Legs Syndrome With Gabapentin Enacarbil: A Randomized Controlled Study
    Bogan, Richard K.
    Cramer Bornemann, Michel A.
    Kushida, Clete A.
    Tran, Pierre V.
    Barrett, Ronald W.
    MAYO CLINIC PROCEEDINGS, 2010, 85 (06) : 512 - 521
  • [29] The long-term effects of the dopamine agonist pramipexole in a proposed restless legs syndrome animal model
    Luo, Feifei
    Li, Chao
    Ondo, William G.
    Xu, Pingyi
    Xie, Wenjie
    Le, Weidong
    SLEEP MEDICINE, 2011, 12 (01) : 41 - 46
  • [30] Loss of response during long-term treatment of restless legs syndrome: Guidelines approved by the International Restless Legs Syndrome Study Group for use in clinical trials
    Garcia-Borreguero, D.
    Allen, R.
    Kohnen, R.
    Benes, H.
    Winkelman, J.
    Hoegl, B.
    Ferini-Strambi, L.
    Zucconi, M.
    Trenkwalder, C.
    SLEEP MEDICINE, 2010, 11 (09) : 956 - 957
12345